11 – 20 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Cerebrovascular endothelin-1 hyper-reactivity is associated with transient receptor potential canonical channels 1 and 6 activation and delayed cerebral hypoperfusion after forebrain ischaemia in rats
(
- Contribution to journal › Article
- 2014
-
Mark
Surgical age and morbidity after arterial switch of transposition of the great arteries
2014) 48th Annual Meeting of the Association for European Paediatric and Congenital Cardiology In Cardiology in the Young 24(S1). p.151-152(
- Contribution to journal › Published meeting abstract
-
Mark
Residual stresses in high speed turning of nickel-based superalloy
(
- Contribution to specialist publication or newspaper › Specialist publication article
- 2013
-
Mark
CD-Sens Can Be a Reliable and Easy-to-Use Complement in the Diagnosis of Allergic Rhinitis
(
- Contribution to journal › Article
- 2012
-
Mark
Resistivity-ip characterisation and short term monitoring at filborna waste deposit
2012) 74th European Association of Geoscientists and Engineers Conference and Exhibition 2012 Incorporating SPE EUROPEC 2012: Responsibly Securing Natural Resources p.4667-4671(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Pumpbehandling räddar liv på barn i väntan på hjärttransplantation.
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2010
-
Mark
Using the resistivity method for leakage detection in a blind test at the Rossvatn embankment dam test facility in Norway
(
- Contribution to journal › Article
-
Mark
Expressional Changes In Cerebrovascular Receptors After Global Cerebral Ischemia
2010) 15th Annual Meeting of the European Council for Cadiovascular Research (ECCR) In Hypertension 56(6). p.1170-1170(
- Contribution to journal › Published meeting abstract
-
Mark
Xolair Is Effective in Allergics with a Low Serum IgE Level.
(
- Contribution to journal › Article
-
Mark
After 6 years with Xolair; a 3-year withdrawal follow-up
(
- Contribution to journal › Article